Advertisement
Australia markets close in 6 hours 1 minute
  • ALL ORDS

    7,410.20
    +4.60 (+0.06%)
     
  • ASX 200

    7,199.00
    +4.10 (+0.06%)
     
  • AUD/USD

    0.6566
    -0.0014 (-0.21%)
     
  • OIL

    71.42
    +0.10 (+0.14%)
     
  • GOLD

    1,997.50
    +3.80 (+0.19%)
     
  • Bitcoin AUD

    62,743.69
    -3,968.54 (-5.95%)
     
  • CMC Crypto 200

    850.06
    -64.75 (-7.08%)
     
  • AUD/EUR

    0.6097
    -0.0013 (-0.22%)
     
  • AUD/NZD

    1.0720
    -0.0021 (-0.20%)
     
  • NZX 50

    11,419.42
    -30.05 (-0.26%)
     
  • NASDAQ

    16,221.73
    +137.05 (+0.85%)
     
  • FTSE

    7,544.89
    -9.58 (-0.13%)
     
  • Dow Jones

    36,404.93
    +157.06 (+0.43%)
     
  • DAX

    16,794.43
    +35.21 (+0.21%)
     
  • Hang Seng

    16,201.49
    -132.88 (-0.81%)
     
  • NIKKEI 225

    32,791.80
    +483.94 (+1.50%)
     

Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Agilon Health (AGL) reported $1.15 billion in revenue for the quarter ended June 2023, representing a year-over-year increase of 71.5%. EPS of -$0.04 for the same period compares to -$0.04 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.11 billion, representing a surprise of +3.39%. The company delivered an EPS surprise of -300.00%, with the consensus EPS estimate being -$0.01.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Agilon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Medicare Advantage Members: 408900 versus the three-analyst average estimate of 433566.7.

  • Average Medicare Advantage membership: 409700 versus the three-analyst average estimate of 404700.

  • Revenues- Medical services: $1.15 billion compared to the $1.12 billion average estimate based on six analysts. The reported number represents a change of +71.4% year over year.

  • Revenues- Other operating: $2.01 million versus $1.58 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +111.4% change.

View all Key Company Metrics for Agilon here>>>

Shares of Agilon have returned +12% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Agilon Health, Inc. (AGL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research